Clinical trial
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
NCT00455715 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00455715 |
|---|---|
| Title | A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia |
| Official title | A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Sildenafil |
| Enrollment | 18 |
| Start date | Feb 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Apr 4, 2007 |
| Last update posted | Jun 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: